Metadoxine regulation of elimination of ethanol and its metabolites from the rat’s body

Authors

  • M. Ya. Golovenko A.V.Bogatsky Physico-Chemical Institute of NAS of Ukraine, Ukraine
  • O. V. Karpova A.V.Bogatsky Physico-Chemical Institute of NAS of Ukraine, Ukraine
  • I. Yu. Borisyuk A.V.Bogatsky Physico-Chemical Institute of NAS of Ukraine, Ukraine

DOI:

https://doi.org/10.24959/cphj.16.1382

Keywords:

metadoxine, ethanol, acetaldehyde, acetate, radiological analysis

Abstract

Development of pathogenetic therapy of acute ethanol poisoning is of undoubted interest since such intoxication is often accompanied by a severe course and high lethality. Taking into account the peculiarities of the ethanol pathological action the treatment of such patients involves the use of drugs with the complex neuro- and hepatoprotective effects. Thereby, the studies for searching new pharmaceutical agents with a wide range of the pharmacological activity and economic availability continue. For a long time the object of researchers’ attention is the chemical compound – pyridoxineL-2-pyrrolidone-5-carboxylate (metadoxine). Till this moment a large number of the experimental data showing a diverse pharmacological profile of the drug action (antioxidant, antisteatotic, anti-inflammatory, antifibrotic, neurotropic) has been accumulated. Paying attention to the facts mentioned above our attention was focused on the detoxification action of metadoxine. Therefore, the aim of this work was to study the effect of metadoxine on the rate of excretion of ethanol and its metabolites in white rats in a preventive single introduction of the drug. The parameters of excretion of acetaldehyde, acetate and the unchanged ethanol with urine and feces have been chosen as a criterion for assessing the effectiveness of the process. Excretion of ethanol by lungs and sweat glands has not been studied because of a negligible contribution of these pathways in the process of ethanol elimination. It has been determined that intraperitoneal introduction of metadoxine in the dose of 200 mg/kg 30 min prior ethanol introduction (orally in the dose of 1 g/kg) accelerates the rate of elimination of ethanol and its metabolites (acetaldehyde and acetate) in rats.

References

Доклінічні дослідження лікарських засобів: Метод. рекоменд. / За ред. А.В.Стефанова. – К.: Вид. дім «Авіценна», 2002. – 527 с.

Кожем’якін Ю.М., Хромов О.С., Філоненко М.А., Сайфетдінова М.А. Науково-практичні рекомендації з утримання лабораторних тварин. – К.: Авіценна, 2002. – 156 с.

Плохинский Н.А. Биометрия. 2-е изд. – М.: Изд-во МГУ, 1970. – 367 с.

Соловьев В.Н., Фирсов А.А., Филов В.А. Фармакокинетика. – М.: Медицина, 1980. – 423 с.

Сухарева Г.В. Алкогольная болезнь печени // Гастроэнтерол. – 2003. – Т. 5, №3. – С. 26-27.

Addolorato G., Ancona C., Capristo E., Gasbarrini G. Metadoxine in the treatment of acute and chronic alcoholism: a review // Int. J. Immunopathol. Pharmacol. – 2003. – Vol. 16. – P. 207-214.

Biochemical Nomenclature and Related Documents. 2nd ed. – Portland Press, 1992. – P. 269-271.

Calabrese V., Carlino S., Chinnici V. et al. // Revista Italiana di Alcologia. – 1986. – Vol. 5. – P. 44-49.

Ethanol and the liver mechanisms and management / Ed. by D.I.N.Sherman, V.Preedy, R.R.Watson. – N.Y.: Taylor & Francis, 2002. – 689 p.

Ink S.L., Henderson L.M., Henderson О. Vitamin B6 metabolism // Annu. Rev. Nutr. – 1984. – Vol. 4 (1). – P. 455-470.

Krahenbuhl S., Brauchli Y., Kummer O. et al. Acute liver failure in two patients with regular alcohol consumption ingesting paracetamol at therapeutic dosage // Digestion. – 2007. – Vol. 75. – P. 232-237.

Lieber C.S. Hepatic metabolic and toxic effects of ethanol // Alcohol Clin. Exp. Res. – 1991. – Vol. 15. – P. 573-592.

Marco C.A., Kelen G.D. Acute intoxication // Emerg. Clin. North. Am. – 1990. – Vol. 8. – P. 731-748.

Vonghia L., Leggio L., Ferrulli A. et al. Acute alcohol intoxication // Eur. J. Intern. Med. – 2008. – Vol. 19 (8). – P. 561-567.

Witschi A. The systemic availability of oral glutathione // Eur. J. Clin. Pharmacol. – 1992. – Vol. 43 (6). – Р. 667-669.

Downloads

Published

2016-09-02

Issue

Vol. 20 No. 3 (2016)

Section

Pre-clinical studies of new drugs

License

Copyright (c) 2016 National University of Pharmacy

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).